Magnetic Resonance Imaging Investigation of Secondary Degeneration of the Mesencephalic Substantia Nigra After Cerebral Infarction

Secondary degeneration of the mesencephalic substantia nigra after cerebral infarction is widely known to occur in animal experiments, but has yet to be sufficiently investigated in human cerebral infarction. This study investigated the background and features of patients exhibiting secondary degene...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of stroke and cerebrovascular diseases 2013, Vol.22 (1), p.58-65
Hauptverfasser: Ohe, Yasuko, MD, Uchino, Akira, MD, PhD, Horiuchi, Yousuke, MD, Maruyama, Hajime, MD, Deguchi, Ichiro, MD, Fukuoka, Takuya, MD, Kato, Yuji, MD, PhD, Nagoya, Harumitsu, MD, Dembo, Tomohisa, MD, PhD, Tanahashi, Norio, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 65
container_issue 1
container_start_page 58
container_title Journal of stroke and cerebrovascular diseases
container_volume 22
creator Ohe, Yasuko, MD
Uchino, Akira, MD, PhD
Horiuchi, Yousuke, MD
Maruyama, Hajime, MD
Deguchi, Ichiro, MD
Fukuoka, Takuya, MD
Kato, Yuji, MD, PhD
Nagoya, Harumitsu, MD
Dembo, Tomohisa, MD, PhD
Tanahashi, Norio, MD, PhD
description Secondary degeneration of the mesencephalic substantia nigra after cerebral infarction is widely known to occur in animal experiments, but has yet to be sufficiently investigated in human cerebral infarction. This study investigated the background and features of patients exhibiting secondary degeneration of the mesencephalic substantia nigra. The subjects comprised 43 patients admitted to our hospital for cerebral infarction between April 2007 and October 2010 showing secondary degeneration of the mesencephalic substantia nigra on cranial magnetic resonance imaging (MRI). We investigated clinical disease type, location of vascular occlusion, lesion site, and time from onset of symptoms to lesion identification by MRI. The clinical disease type was cardiogenic embolism in 29 patients (67%), atheromatous embolism (artery to artery) in 8 patients (19%), embolism (origin unknown) in 2 patients (5%), infarction after coil embolization for internal carotid aneurysm in 1 patient (2%), arterial dissection in 2 patients (5%), and vasculitis due to Takayasu disease in 1 patient (2%). Magnetic resonance angiography (MRA) identified the occluded vessel as the internal carotid artery in 19 patients (44%), the middle cerebral artery (M1) in 20 patients (47%), and the middle cerebral artery (M2) in 3 patients (7%); MRA was not performed in 1 patient (2%). The cerebral infarctions were striatal in 7 patients (16%) and striatal and cortical in 36 patients (84%). Hyperintense regions in the mesencephalic substantia nigra were observed in all patients after 7-28 days (mean, 13.3 days) on diffusion-weighted imaging or fluid-attenuated inversion recovery and T2-weighted MRI. Most patients with secondary degeneration of the substantia nigra demonstrated clinical disease comprising vascular occlusion of the internal carotid artery or the neighborhood of the middle cerebral artery, which was envisaged to cause a sudden drop in brain circulation across a wide area. Striatal infarctions were observed in all patients. Secondary degeneration of the substantia nigra appeared at 1-4 weeks after onset and disappeared after several months.
doi_str_mv 10.1016/j.jstrokecerebrovasdis.2011.06.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1273408894</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1052305711001613</els_id><sourcerecordid>1273408894</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-f689810f458f04b64617b8debed59abe7626024e7ae8d769c1b717d378435e843</originalsourceid><addsrcrecordid>eNqVUk1v1DAQjRCIlsJfQD4ipARPEjveC1JZvlbagsTC2XKcSeo0a29tZ6Ve-eU4bOkBceFiW_KbN_Pemyx7DbQACvzNWIwheneDGj223h1V6EwoSgpQUF5Qyh9l58CqMhcM4HF6U1bmFWXNWfYshJEmIBPsaXZWQiNqzsvz7OeVGixGo8k3DM4qq5Fs9mowdiAbe8QQzaCicZa4nuxQO9spf0fe44AW_cNPvEZyhQFT-eFaTYluN7chKhuNIl_M4BW57CN6sv49upoSea-8XuqfZ096NQV8cX9fZD8-fvi-_pxvv37arC-3ua7ZKuY9FysBtK-Z6Gnd8ppD04oOW-zYSrXY8JLTssZGoegavtLQNtB0VVJaMUzHRfbqxHvw7nZOyuTeBI3TpCy6OUgom6qmQqwW6LsTVHsXgsdeHrzZJ-ESqFyykKP8VxZyyUJSLlMWieTlfb-53WP3QPHH_ATYngCYVB8Nehm0WSzsjEcdZefM__V7-xednow1Wk03eIdhdLO3yV8JMpSSyt2yHctyAKTF4FBVvwDJGr_0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1273408894</pqid></control><display><type>article</type><title>Magnetic Resonance Imaging Investigation of Secondary Degeneration of the Mesencephalic Substantia Nigra After Cerebral Infarction</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Ohe, Yasuko, MD ; Uchino, Akira, MD, PhD ; Horiuchi, Yousuke, MD ; Maruyama, Hajime, MD ; Deguchi, Ichiro, MD ; Fukuoka, Takuya, MD ; Kato, Yuji, MD, PhD ; Nagoya, Harumitsu, MD ; Dembo, Tomohisa, MD, PhD ; Tanahashi, Norio, MD, PhD</creator><creatorcontrib>Ohe, Yasuko, MD ; Uchino, Akira, MD, PhD ; Horiuchi, Yousuke, MD ; Maruyama, Hajime, MD ; Deguchi, Ichiro, MD ; Fukuoka, Takuya, MD ; Kato, Yuji, MD, PhD ; Nagoya, Harumitsu, MD ; Dembo, Tomohisa, MD, PhD ; Tanahashi, Norio, MD, PhD</creatorcontrib><description>Secondary degeneration of the mesencephalic substantia nigra after cerebral infarction is widely known to occur in animal experiments, but has yet to be sufficiently investigated in human cerebral infarction. This study investigated the background and features of patients exhibiting secondary degeneration of the mesencephalic substantia nigra. The subjects comprised 43 patients admitted to our hospital for cerebral infarction between April 2007 and October 2010 showing secondary degeneration of the mesencephalic substantia nigra on cranial magnetic resonance imaging (MRI). We investigated clinical disease type, location of vascular occlusion, lesion site, and time from onset of symptoms to lesion identification by MRI. The clinical disease type was cardiogenic embolism in 29 patients (67%), atheromatous embolism (artery to artery) in 8 patients (19%), embolism (origin unknown) in 2 patients (5%), infarction after coil embolization for internal carotid aneurysm in 1 patient (2%), arterial dissection in 2 patients (5%), and vasculitis due to Takayasu disease in 1 patient (2%). Magnetic resonance angiography (MRA) identified the occluded vessel as the internal carotid artery in 19 patients (44%), the middle cerebral artery (M1) in 20 patients (47%), and the middle cerebral artery (M2) in 3 patients (7%); MRA was not performed in 1 patient (2%). The cerebral infarctions were striatal in 7 patients (16%) and striatal and cortical in 36 patients (84%). Hyperintense regions in the mesencephalic substantia nigra were observed in all patients after 7-28 days (mean, 13.3 days) on diffusion-weighted imaging or fluid-attenuated inversion recovery and T2-weighted MRI. Most patients with secondary degeneration of the substantia nigra demonstrated clinical disease comprising vascular occlusion of the internal carotid artery or the neighborhood of the middle cerebral artery, which was envisaged to cause a sudden drop in brain circulation across a wide area. Striatal infarctions were observed in all patients. Secondary degeneration of the substantia nigra appeared at 1-4 weeks after onset and disappeared after several months.</description><identifier>ISSN: 1052-3057</identifier><identifier>EISSN: 1532-8511</identifier><identifier>DOI: 10.1016/j.jstrokecerebrovasdis.2011.06.006</identifier><identifier>PMID: 21784662</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Cardiovascular ; cerebral infarction ; Cerebral Infarction - etiology ; Cerebral Infarction - pathology ; Diffusion Magnetic Resonance Imaging ; Female ; Humans ; Magnetic Resonance Angiography ; Male ; mesencephalic substantia nigra ; Middle Aged ; Nerve Degeneration ; Neurology ; Predictive Value of Tests ; Risk Factors ; Secondary degeneration ; Substantia Nigra - pathology ; Time Factors</subject><ispartof>Journal of stroke and cerebrovascular diseases, 2013, Vol.22 (1), p.58-65</ispartof><rights>National Stroke Association</rights><rights>2013 National Stroke Association</rights><rights>Copyright © 2013 National Stroke Association. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-f689810f458f04b64617b8debed59abe7626024e7ae8d769c1b717d378435e843</citedby><cites>FETCH-LOGICAL-c459t-f689810f458f04b64617b8debed59abe7626024e7ae8d769c1b717d378435e843</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2011.06.006$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,4024,27923,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21784662$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ohe, Yasuko, MD</creatorcontrib><creatorcontrib>Uchino, Akira, MD, PhD</creatorcontrib><creatorcontrib>Horiuchi, Yousuke, MD</creatorcontrib><creatorcontrib>Maruyama, Hajime, MD</creatorcontrib><creatorcontrib>Deguchi, Ichiro, MD</creatorcontrib><creatorcontrib>Fukuoka, Takuya, MD</creatorcontrib><creatorcontrib>Kato, Yuji, MD, PhD</creatorcontrib><creatorcontrib>Nagoya, Harumitsu, MD</creatorcontrib><creatorcontrib>Dembo, Tomohisa, MD, PhD</creatorcontrib><creatorcontrib>Tanahashi, Norio, MD, PhD</creatorcontrib><title>Magnetic Resonance Imaging Investigation of Secondary Degeneration of the Mesencephalic Substantia Nigra After Cerebral Infarction</title><title>Journal of stroke and cerebrovascular diseases</title><addtitle>J Stroke Cerebrovasc Dis</addtitle><description>Secondary degeneration of the mesencephalic substantia nigra after cerebral infarction is widely known to occur in animal experiments, but has yet to be sufficiently investigated in human cerebral infarction. This study investigated the background and features of patients exhibiting secondary degeneration of the mesencephalic substantia nigra. The subjects comprised 43 patients admitted to our hospital for cerebral infarction between April 2007 and October 2010 showing secondary degeneration of the mesencephalic substantia nigra on cranial magnetic resonance imaging (MRI). We investigated clinical disease type, location of vascular occlusion, lesion site, and time from onset of symptoms to lesion identification by MRI. The clinical disease type was cardiogenic embolism in 29 patients (67%), atheromatous embolism (artery to artery) in 8 patients (19%), embolism (origin unknown) in 2 patients (5%), infarction after coil embolization for internal carotid aneurysm in 1 patient (2%), arterial dissection in 2 patients (5%), and vasculitis due to Takayasu disease in 1 patient (2%). Magnetic resonance angiography (MRA) identified the occluded vessel as the internal carotid artery in 19 patients (44%), the middle cerebral artery (M1) in 20 patients (47%), and the middle cerebral artery (M2) in 3 patients (7%); MRA was not performed in 1 patient (2%). The cerebral infarctions were striatal in 7 patients (16%) and striatal and cortical in 36 patients (84%). Hyperintense regions in the mesencephalic substantia nigra were observed in all patients after 7-28 days (mean, 13.3 days) on diffusion-weighted imaging or fluid-attenuated inversion recovery and T2-weighted MRI. Most patients with secondary degeneration of the substantia nigra demonstrated clinical disease comprising vascular occlusion of the internal carotid artery or the neighborhood of the middle cerebral artery, which was envisaged to cause a sudden drop in brain circulation across a wide area. Striatal infarctions were observed in all patients. Secondary degeneration of the substantia nigra appeared at 1-4 weeks after onset and disappeared after several months.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Cardiovascular</subject><subject>cerebral infarction</subject><subject>Cerebral Infarction - etiology</subject><subject>Cerebral Infarction - pathology</subject><subject>Diffusion Magnetic Resonance Imaging</subject><subject>Female</subject><subject>Humans</subject><subject>Magnetic Resonance Angiography</subject><subject>Male</subject><subject>mesencephalic substantia nigra</subject><subject>Middle Aged</subject><subject>Nerve Degeneration</subject><subject>Neurology</subject><subject>Predictive Value of Tests</subject><subject>Risk Factors</subject><subject>Secondary degeneration</subject><subject>Substantia Nigra - pathology</subject><subject>Time Factors</subject><issn>1052-3057</issn><issn>1532-8511</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVUk1v1DAQjRCIlsJfQD4ipARPEjveC1JZvlbagsTC2XKcSeo0a29tZ6Ve-eU4bOkBceFiW_KbN_Pemyx7DbQACvzNWIwheneDGj223h1V6EwoSgpQUF5Qyh9l58CqMhcM4HF6U1bmFWXNWfYshJEmIBPsaXZWQiNqzsvz7OeVGixGo8k3DM4qq5Fs9mowdiAbe8QQzaCicZa4nuxQO9spf0fe44AW_cNPvEZyhQFT-eFaTYluN7chKhuNIl_M4BW57CN6sv49upoSea-8XuqfZ096NQV8cX9fZD8-fvi-_pxvv37arC-3ua7ZKuY9FysBtK-Z6Gnd8ppD04oOW-zYSrXY8JLTssZGoegavtLQNtB0VVJaMUzHRfbqxHvw7nZOyuTeBI3TpCy6OUgom6qmQqwW6LsTVHsXgsdeHrzZJ-ESqFyykKP8VxZyyUJSLlMWieTlfb-53WP3QPHH_ATYngCYVB8Nehm0WSzsjEcdZefM__V7-xednow1Wk03eIdhdLO3yV8JMpSSyt2yHctyAKTF4FBVvwDJGr_0</recordid><startdate>2013</startdate><enddate>2013</enddate><creator>Ohe, Yasuko, MD</creator><creator>Uchino, Akira, MD, PhD</creator><creator>Horiuchi, Yousuke, MD</creator><creator>Maruyama, Hajime, MD</creator><creator>Deguchi, Ichiro, MD</creator><creator>Fukuoka, Takuya, MD</creator><creator>Kato, Yuji, MD, PhD</creator><creator>Nagoya, Harumitsu, MD</creator><creator>Dembo, Tomohisa, MD, PhD</creator><creator>Tanahashi, Norio, MD, PhD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2013</creationdate><title>Magnetic Resonance Imaging Investigation of Secondary Degeneration of the Mesencephalic Substantia Nigra After Cerebral Infarction</title><author>Ohe, Yasuko, MD ; Uchino, Akira, MD, PhD ; Horiuchi, Yousuke, MD ; Maruyama, Hajime, MD ; Deguchi, Ichiro, MD ; Fukuoka, Takuya, MD ; Kato, Yuji, MD, PhD ; Nagoya, Harumitsu, MD ; Dembo, Tomohisa, MD, PhD ; Tanahashi, Norio, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-f689810f458f04b64617b8debed59abe7626024e7ae8d769c1b717d378435e843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Cardiovascular</topic><topic>cerebral infarction</topic><topic>Cerebral Infarction - etiology</topic><topic>Cerebral Infarction - pathology</topic><topic>Diffusion Magnetic Resonance Imaging</topic><topic>Female</topic><topic>Humans</topic><topic>Magnetic Resonance Angiography</topic><topic>Male</topic><topic>mesencephalic substantia nigra</topic><topic>Middle Aged</topic><topic>Nerve Degeneration</topic><topic>Neurology</topic><topic>Predictive Value of Tests</topic><topic>Risk Factors</topic><topic>Secondary degeneration</topic><topic>Substantia Nigra - pathology</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ohe, Yasuko, MD</creatorcontrib><creatorcontrib>Uchino, Akira, MD, PhD</creatorcontrib><creatorcontrib>Horiuchi, Yousuke, MD</creatorcontrib><creatorcontrib>Maruyama, Hajime, MD</creatorcontrib><creatorcontrib>Deguchi, Ichiro, MD</creatorcontrib><creatorcontrib>Fukuoka, Takuya, MD</creatorcontrib><creatorcontrib>Kato, Yuji, MD, PhD</creatorcontrib><creatorcontrib>Nagoya, Harumitsu, MD</creatorcontrib><creatorcontrib>Dembo, Tomohisa, MD, PhD</creatorcontrib><creatorcontrib>Tanahashi, Norio, MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of stroke and cerebrovascular diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ohe, Yasuko, MD</au><au>Uchino, Akira, MD, PhD</au><au>Horiuchi, Yousuke, MD</au><au>Maruyama, Hajime, MD</au><au>Deguchi, Ichiro, MD</au><au>Fukuoka, Takuya, MD</au><au>Kato, Yuji, MD, PhD</au><au>Nagoya, Harumitsu, MD</au><au>Dembo, Tomohisa, MD, PhD</au><au>Tanahashi, Norio, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Magnetic Resonance Imaging Investigation of Secondary Degeneration of the Mesencephalic Substantia Nigra After Cerebral Infarction</atitle><jtitle>Journal of stroke and cerebrovascular diseases</jtitle><addtitle>J Stroke Cerebrovasc Dis</addtitle><date>2013</date><risdate>2013</risdate><volume>22</volume><issue>1</issue><spage>58</spage><epage>65</epage><pages>58-65</pages><issn>1052-3057</issn><eissn>1532-8511</eissn><abstract>Secondary degeneration of the mesencephalic substantia nigra after cerebral infarction is widely known to occur in animal experiments, but has yet to be sufficiently investigated in human cerebral infarction. This study investigated the background and features of patients exhibiting secondary degeneration of the mesencephalic substantia nigra. The subjects comprised 43 patients admitted to our hospital for cerebral infarction between April 2007 and October 2010 showing secondary degeneration of the mesencephalic substantia nigra on cranial magnetic resonance imaging (MRI). We investigated clinical disease type, location of vascular occlusion, lesion site, and time from onset of symptoms to lesion identification by MRI. The clinical disease type was cardiogenic embolism in 29 patients (67%), atheromatous embolism (artery to artery) in 8 patients (19%), embolism (origin unknown) in 2 patients (5%), infarction after coil embolization for internal carotid aneurysm in 1 patient (2%), arterial dissection in 2 patients (5%), and vasculitis due to Takayasu disease in 1 patient (2%). Magnetic resonance angiography (MRA) identified the occluded vessel as the internal carotid artery in 19 patients (44%), the middle cerebral artery (M1) in 20 patients (47%), and the middle cerebral artery (M2) in 3 patients (7%); MRA was not performed in 1 patient (2%). The cerebral infarctions were striatal in 7 patients (16%) and striatal and cortical in 36 patients (84%). Hyperintense regions in the mesencephalic substantia nigra were observed in all patients after 7-28 days (mean, 13.3 days) on diffusion-weighted imaging or fluid-attenuated inversion recovery and T2-weighted MRI. Most patients with secondary degeneration of the substantia nigra demonstrated clinical disease comprising vascular occlusion of the internal carotid artery or the neighborhood of the middle cerebral artery, which was envisaged to cause a sudden drop in brain circulation across a wide area. Striatal infarctions were observed in all patients. Secondary degeneration of the substantia nigra appeared at 1-4 weeks after onset and disappeared after several months.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>21784662</pmid><doi>10.1016/j.jstrokecerebrovasdis.2011.06.006</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1052-3057
ispartof Journal of stroke and cerebrovascular diseases, 2013, Vol.22 (1), p.58-65
issn 1052-3057
1532-8511
language eng
recordid cdi_proquest_miscellaneous_1273408894
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adult
Aged
Aged, 80 and over
Cardiovascular
cerebral infarction
Cerebral Infarction - etiology
Cerebral Infarction - pathology
Diffusion Magnetic Resonance Imaging
Female
Humans
Magnetic Resonance Angiography
Male
mesencephalic substantia nigra
Middle Aged
Nerve Degeneration
Neurology
Predictive Value of Tests
Risk Factors
Secondary degeneration
Substantia Nigra - pathology
Time Factors
title Magnetic Resonance Imaging Investigation of Secondary Degeneration of the Mesencephalic Substantia Nigra After Cerebral Infarction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T23%3A45%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Magnetic%20Resonance%20Imaging%20Investigation%20of%20Secondary%20Degeneration%20of%20the%20Mesencephalic%20Substantia%20Nigra%20After%20Cerebral%20Infarction&rft.jtitle=Journal%20of%20stroke%20and%20cerebrovascular%20diseases&rft.au=Ohe,%20Yasuko,%20MD&rft.date=2013&rft.volume=22&rft.issue=1&rft.spage=58&rft.epage=65&rft.pages=58-65&rft.issn=1052-3057&rft.eissn=1532-8511&rft_id=info:doi/10.1016/j.jstrokecerebrovasdis.2011.06.006&rft_dat=%3Cproquest_cross%3E1273408894%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1273408894&rft_id=info:pmid/21784662&rft_els_id=1_s2_0_S1052305711001613&rfr_iscdi=true